Julia E Aledort

Summary

Affiliation: RAND Corporation
Country: USA

Publications

  1. ncbi The cost effectiveness of gonorrhea screening in urban emergency departments
    Julia E Aledort
    Harvard Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, USA
    Sex Transm Dis 32:425-36. 2005
  2. ncbi Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base
    Julia E Aledort
    RAND Center for Domestic and International Health Security, 1776 Main Street, Santa Monica, California, USA
    BMC Public Health 7:208. 2007
  3. ncbi Cost implications of improving blood pressure management among U.S. adults
    Teryl K Nuckols
    RAND Corporation, 1776 Main Street, Santa Monica, CA 90407, USA
    Health Serv Res 46:1124-57. 2011
  4. ncbi Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom
    David L Veenstra
    University of Washington, Seattle, Washington 98195, USA
    Eur J Gastroenterol Hepatol 19:631-8. 2007
  5. ncbi Reducing the burden of sexually transmitted infections in resource-limited settings: the role of improved diagnostics
    Julia E Aledort
    RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, California 90407-2138, USA
    Nature 444:59-72. 2006

Collaborators

Detail Information

Publications5

  1. ncbi The cost effectiveness of gonorrhea screening in urban emergency departments
    Julia E Aledort
    Harvard Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, USA
    Sex Transm Dis 32:425-36. 2005
    ..The prevalence of gonorrhea (GC) among adolescent and young women attending some urban emergency departments (EDs) ranges from 1% to 7%, but historically screening has not been logistically practical...
  2. ncbi Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base
    Julia E Aledort
    RAND Center for Domestic and International Health Security, 1776 Main Street, Santa Monica, California, USA
    BMC Public Health 7:208. 2007
    ....
  3. ncbi Cost implications of improving blood pressure management among U.S. adults
    Teryl K Nuckols
    RAND Corporation, 1776 Main Street, Santa Monica, CA 90407, USA
    Health Serv Res 46:1124-57. 2011
    ..To examine the cost-effectiveness of improving blood pressure management from the payer perspective...
  4. ncbi Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom
    David L Veenstra
    University of Washington, Seattle, Washington 98195, USA
    Eur J Gastroenterol Hepatol 19:631-8. 2007
    ..We assessed the clinical outcomes and costs, from the perspective of the UK National Health Service, of 48 weeks of peginterferon alpha-2a (40 kDa) vs. 4 years of lamivudine...
  5. ncbi Reducing the burden of sexually transmitted infections in resource-limited settings: the role of improved diagnostics
    Julia E Aledort
    RAND Corporation, 1776 Main Street, PO Box 2138, Santa Monica, California 90407-2138, USA
    Nature 444:59-72. 2006